Co-morbidities

AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s

Nir Uriel

Watch time: 34m 39s (5 videos)

Giovanni Battista Bonfioli, Matteo Pagnesi, Daniela Tomasoni, et al

Read time: 15m 45s
Tirzepatide Benefits in HFpEF Consistent Across Obesity Levels, SUMMIT Analysis Shows

Radcliffe CVRM

James Burton, Clara Bonanad Lozano, Csaba Kovesdy, et al

Watch time: 1h 1m 16s (5 videos)

Broadcast

Cardiovascular Renal Metabolic

Heart Failure
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano, Aaron Wong, et al

Watch time: 1h 3m 30s

Mohammed El-Sheikh, Nora Olsen El Caidi, Aginsha Kandiah, et al

Read time: 20m 9s

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2025 – Day Two

Nisha Bansal, Antonio Ceriello, David Wheeler, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2025 – Day One

Nisha Bansal, Antonio Ceriello, David Wheeler, et al

Dinesh Khullar, Anish Kumar Gupta, Kulwant Singh

Read time: 21m 40s

Laibah Arshad Khan, Adeena Jamil, Stephen J Greene, et al

Read time: 37m 48s

Andrew JS Coats, Stefan Anker

AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s

Dinesh Khullar, Anish Kumar Gupta, Kulwant Singh

Read time: 21m 40s

Giulio Balestrieri, Raul Limonta, Enrico Ponti, et al

Read time: 18m 10s
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s

David K Ryan, Debasish Banerjee, Fadi Jouhra

Read time: 10m

Rishi Sethi, Pravesh Vishwakarma, Akshyaya Pradhan

Read time: 19m 41s

Giovanni Battista Bonfioli, Matteo Pagnesi, Daniela Tomasoni, et al

Read time: 15m 45s

Laibah Arshad Khan, Adeena Jamil, Stephen J Greene, et al

Read time: 37m 48s

Aleksandra Bykova, Maria Serova, Maria Chashkina, et al

Read time: 22m 11s

Fausto J Pinto, John Spertus, , et al

James Burton, Clara Bonanad Lozano, Csaba Kovesdy, et al

Watch time: 1h 1m 16s (5 videos)

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Media

HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal

Watch time: 8m 47s

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day Two

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day One

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Shelley Zieroth

Watch time: 3m 59s (1 video)

Broadcast

Heart Failure
Hyperkalaemia in Cardiorenal Disease

Shelley Zieroth, Clara Bonanad Lozano, Andrew Frankel, et al

Watch time: 1h 34m 52s

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s

Andrew JS Coats, Stefan Anker

Media

AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s

Broadcast

Cardiovascular Renal Metabolic

Heart Failure
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano, Aaron Wong, et al

Watch time: 1h 3m 30s

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2025 – Day Two

Nisha Bansal, Antonio Ceriello, David Wheeler, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2025 – Day One

Nisha Bansal, Antonio Ceriello, David Wheeler, et al

Broadcast

Heart Failure
Medical Options for Advanced HFpEF/HFmrEF Patients

Biykem Bozkurt, Muthiah Vaduganathan, , et al

Watch time: 1h 1m 12s

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2024 - Day 2

Antonio Ceriello, Ileana L Piña, Gianluigi Savarese, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2024 - Day 1

Antonio Ceriello, Ileana L Piña, Gianluigi Savarese, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day Two

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day One

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Broadcast

Heart Failure
Hyperkalaemia in Cardiorenal Disease

Shelley Zieroth, Clara Bonanad Lozano, Andrew Frankel, et al

Watch time: 1h 34m 52s

Nir Uriel

Watch time: 34m 39s (5 videos)

Articles

Understanding the Role of GLP-1 RAs in the Treatment of HF

Giovanni Battista Bonfioli

,

Matteo Pagnesi

,

Daniela Tomasoni

,

Amina Rakisheva

,

Marco Metra

,

Published:

14 August 2025

Citation:

Cardiac Failure Review 2025;11:e19.

DOI:

https://doi.org/10.15420/cfr.2025.10
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 346
  • Downloads: Downloads 66
  • Read time: 15m 45s

The True Obesity Paradox: Obese and Malnourished?

Mohammed El-Sheikh

,

Nora Olsen El Caidi

,

Aginsha Kandiah

,

Sandra Henriette Tonning

,

Ida Arentz Taraldsen

,

Frederik Dencker Wisborg

,

Ove Andersen

,

Jens Dahlgaard Hove

,

Johannes Grand

,

Published:

19 February 2025

Citation:

Cardiac Failure Review 2025;11:e03.

DOI:

https://doi.org/10.15420/cfr.2024.35
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 595
  • Downloads: Downloads 60
  • Citations: 7
  • Read time: 20m 9s

Finerenone: Will It Be a Game-changer?

Dinesh Khullar

,

Anish Kumar Gupta

,

Kulwant Singh

,

Published:

23 December 2024

Citation:

Cardiac Failure Review 2024;10:e19.

DOI:

https://doi.org/10.15420/cfr.2024.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 4205
  • Downloads: Downloads 338
  • Citations: 5
  • Read time: 21m 40s

Aldosterone and Potassium in Heart Failure

Laibah Arshad Khan

,

Adeena Jamil

,

Stephen J Greene

,

Muhammad Shahzeb Khan

,

Javed Butler

,

Published:

20 December 2024

Citation:

Cardiac Failure Review 2024;10:e18.

DOI:

https://doi.org/10.15420/cfr.2024.09
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1578
  • Downloads: Downloads 232
  • Citations: 4
  • Read time: 37m 48s